NHS framework agreement for supply of seasonal influenza vaccine, for delivery during the 2017/18 flu season
key details
| Status | complete |
|---|---|
| Category (CPV) | 33651000 |
| Deadline | 8 Jun 2016 |
| Contract start | 1 Dec 2016 |
| Contract end | 30 Nov 2017 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-a16c420e-adc9-11e6-9901-0019b9f3037b |
Awards (5)
This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| BGP Products shared | £0 | 12 Sept 2016 | active |
| GlaxoSmithKline UK Ltd shared | £0 | 12 Sept 2016 | active |
| Pfizer Ltd shared | £0 | 12 Sept 2016 | active |
| Sanofi Pasteur MSD Ltd shared | £0 | 12 Sept 2016 | active |
| Seqirus Vaccines Ltd shared | £0 | 12 Sept 2016 | active |
description
This procurement exercise is intended to establish a framework agreement against which NHS hospitals would call off their requirements for seasonal influenza vaccines. This framework agreement will enable hospital, trusts and secondary care organisations access to seasonal flu vaccine for front line healthcare workers and those in at risks groupshospitalised during the annual northern hemisphere flu. season 2017/18.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 10 Aug 2015 | Planning (planning) | · | ocds-b5fd17-a626563b-adc8-11e6-9901-0019b9f3037b-71124-cm-phv-15-5489 |
| 18 Nov 2016 | Award (award) | · | 05b07f7b-8a72-4f15-a908-6ddcbfd0da60-95862 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Contract for the supply of Meales, Mumps and Rubella (MMR) vaccine · DEPARTMENT OF HEALTH
- Contract for supply combined atropine & pralidoxime chloride auto-injector · Department of Health
- Contract for the supply of Botulism Antitoxin Heptavalent ((A,B,C,D,E,F,G) - (Equine)) · Department of Health
- Inactivated flu vaccine 2018 season · DEPARTMENT OF HEALTH
- Contract for the supply of human papillomavrius vaccine · COMMERCIAL MEDICINES UNIT
- Contract for the supply of BCG vaccine · COMMERCIAL MEDICINES UNIT
- Contract for the supply of Measles, Mumps and Rubella vaccine (MMR) · DEPARTMENT OF HEALTH
- Contract for the supply if diphtheria, tetanus, pertussis and poliomyelitis vaccine · DEPARTMENT OF HEALTH
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.